Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Geneva
- Most recent report
- 6-K, filed Jul 8, 2026
- Filings on record
- 263 filings
- On EDGAR
- CIK 1574232
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 128
- 6-K Report a foreign issuer made public elsewhere Jul 8, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 30, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 25, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 5, 2026
- 20-F Annual report, foreign issuer May 15, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 30, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 29, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 23, 2026
Prospectuses and Registrations 8 of 34
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- F-3 Nov 19, 2025
- 424B3 Prospectus supplement for an offering Apr 24, 2024
- POS AM Post-effective amendment to a registration Apr 18, 2024
- 424B5 Prospectus supplement for an offering Jan 30, 2024
- 424B3 Prospectus supplement for an offering Nov 30, 2023
- POS AM Post-effective amendment to a registration Nov 29, 2023
- 424B3 Prospectus supplement for an offering Oct 23, 2023
Ownership 8 of 39
- 3 Insider reported their initial holding Mar 25, 2026
- 3 Insider reported their initial holding Mar 25, 2026
- 3 Insider reported their initial holding Mar 25, 2026
- 3 Insider reported their initial holding Mar 25, 2026
- 3 Insider reported their initial holding Mar 25, 2026
- 3 Insider reported their initial holding Mar 18, 2026
- 3 Insider reported their initial holding Mar 18, 2026
- 3 Insider reported their initial holding Mar 18, 2026
Other 8 of 62
- NT 20-F Apr 30, 2026
- EFFECT Notice that a registration became effective Dec 5, 2025
- CORRESP Reply to SEC staff Dec 3, 2025
- NT 20-F Apr 30, 2025
- EFFECT Notice that a registration became effective Apr 22, 2024
- 6-K/A Report a foreign issuer made public elsewhere, amended Dec 21, 2023
- EFFECT Notice that a registration became effective Nov 29, 2023
- F-6 POS Oct 6, 2023
Everything here comes from Addex Therapeutics Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.